Candriam S.C.A. Sells 5,248 Shares of IDEX Corporation $IEX

Candriam S.C.A. reduced its stake in IDEX Corporation (NYSE:IEX) by 7.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,631 shares of the industrial products company’s stock after selling 5,248 shares during the quarter. Candriam S.C.A.’s holdings in IDEX were worth $12,440,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Numerai GP LLC raised its stake in IDEX by 19.4% during the third quarter. Numerai GP LLC now owns 62,313 shares of the industrial products company’s stock valued at $10,142,000 after buying an additional 10,114 shares during the last quarter. Deprince Race & Zollo Inc. grew its stake in shares of IDEX by 4.3% in the fourth quarter. Deprince Race & Zollo Inc. now owns 359,152 shares of the industrial products company’s stock worth $63,908,000 after acquiring an additional 14,952 shares during the last quarter. Assenagon Asset Management S.A. increased its holdings in shares of IDEX by 13.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 62,606 shares of the industrial products company’s stock valued at $11,140,000 after acquiring an additional 7,559 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of IDEX by 4.5% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 160,520 shares of the industrial products company’s stock valued at $28,743,000 after acquiring an additional 6,901 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in shares of IDEX by 2,690.4% in the 4th quarter. SG Americas Securities LLC now owns 32,508 shares of the industrial products company’s stock worth $5,784,000 after purchasing an additional 31,343 shares during the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.

IDEX Stock Performance

Shares of NYSE IEX opened at $222.33 on Monday. The firm’s 50-day moving average price is $217.35 and its 200-day moving average price is $204.06. The company has a quick ratio of 2.40, a current ratio of 3.39 and a debt-to-equity ratio of 0.46. The company has a market cap of $16.46 billion, a PE ratio of 32.89, a PEG ratio of 2.18 and a beta of 0.98. IDEX Corporation has a 52-week low of $157.25 and a 52-week high of $230.18.

IDEX (NYSE:IEX) last released its quarterly earnings data on Wednesday, April 29th. The industrial products company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.22. IDEX had a net margin of 14.38% and a return on equity of 15.29%. The firm had revenue of $886.90 million during the quarter, compared to analysts’ expectations of $845.58 million. During the same period in the previous year, the company earned $1.75 earnings per share. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. As a group, analysts anticipate that IDEX Corporation will post 8.49 EPS for the current year.

IDEX Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 24th. Investors of record on Monday, July 6th will be given a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Monday, July 6th. IDEX’s dividend payout ratio is 43.20%.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Robert W. Baird set a $257.00 price objective on shares of IDEX in a research report on Thursday, April 30th. Stifel Nicolaus set a $250.00 target price on shares of IDEX in a report on Thursday, April 30th. Oppenheimer reiterated an “outperform” rating and set a $250.00 price target (up from $242.00) on shares of IDEX in a report on Tuesday, June 2nd. BMO Capital Markets began coverage on shares of IDEX in a research report on Friday, March 27th. They set a “market perform” rating and a $214.00 price target for the company. Finally, Weiss Ratings upgraded shares of IDEX from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, June 24th. Six equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $241.11.

Insiders Place Their Bets

In other IDEX news, CEO Eric D. Ashleman sold 15,385 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $215.22, for a total value of $3,311,159.70. Following the transaction, the chief executive officer directly owned 66,658 shares of the company’s stock, valued at approximately $14,346,134.76. This trade represents a 18.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.50% of the company’s stock.

About IDEX

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.